Progenitor Cells and Vascular Repair

Cardiovascular Regeneration and Stem Cell Therapy

Volumn , Issue , 2007, Pages 57-65

  Mandal, Kaushik ^a   Jahangiri, Marjan ^a   Xu, Qingbo ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Endothelial progenitor cells (EPCS); Endothelium; Neointimal hyperplasia; Progenitor cells; Venous bypass grafts

Indexed keywords

EID: 84859636579     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470988909.ch7     Document Type: Chapter

References (56)

1. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418:41-49.
2. Xu Q. The impact of progenitor cells in atherosclerosis. Nat Clin Pract Cardiovasc Med 2006; 3:94-101.
3. AsaharaT,MuroharaT, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275:964-967.
4. Walter DH, Dimmeler S. Endothelial progenitor cells: regulation and contribution to adult neovascularization. Herz 2002; 27:579-588.
5. Burger PE, Coetzee S, McKeehan WL, et al. Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells. Blood 2002; 100:3527-3535.
6. Salven P,Mustjoki S, Alitalo R, et al. VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood 2003; 101:168-172.
7. Hu Y, Zhang Z, Torsney E, et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 2004; 113:1258-1265.
8. Tintut Y, Alfonso Z, Saini T, et al. Multilineage potential of cells from the artery wall. Circulation 2003; 108:2505-2510.
9. Lin Y, Chen X, Yan Z, et al.Multilineage differentiation of adipose-derived stromal cells from GFP transgenic mice. Mol Cell Biochem 2006; 285:69-78.
10. Prunet-Marcassus B, Cousin B, Caton D, Andre M, Penicaud L, Casteilla L. From heterogeneity to plasticity in adipose tissues: site-specific differences. Exp Cell Res 2006; 312:727-736.
11. Xu QB. Endothelial progenitor cells in angiogenesis. Sheng Li Xue Bao 2005; 57:1-6.
12. Hu Y, Davison F, Zhang Z, Xu Q. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation 2003; 108:3122-3127.
13. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83:1774-1777.
14. Doornekamp F, Borst C, Post MJ. Endothelial cell recovery and intimal hyperplasia after endothelium removal with or without smoothmuscle cell necrosis in the rabbit carotid artery. J Vasc Res 1966; 33:146-155.
15. Haudenschild CC, Schwartz SM. Endothelial regeneration. II. Restitution of endothelial continuity. Lab Invest 1979; 41:407-418.
16. Clowes A, Kohler TR. Anatomy, physiology and pharmacology of the vascular wall. In MartinWS (ed.): Vascular Surgery. Philadelphia: WB Saunders, 205-223, 1993.
17. Schwartz RS. Neointima and arterial injury: dogs, rats, pigs, and more. Lab Invest 1994; 71:789-791.
18. Schwartz RS, van der Giessen WJ, Holmes DR, Jr. Biomimicry, vascular restenosis and coronary stents. Semin Interv Cardiol 1998; 3:151-156.
19. Moulton KS. Plaque angiogenesis and atherosclerosis. Curr Atheroscler Rep 2001; 3:225-233.
20. Barker SG, Tilling LC, Miller GC, et al. The adventitia and atherogenesis: removal initiates intimal proliferation in the rabbit which regresses on generation of a "neoadventitia." Atherosclerosis 1994; 105:131-144.
21. Mayr M, Li C, Zou Y, et al. Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases. FASEB J 2000; 14:261-270.
22. Xu Q, Zhang Z, Davison F, Hu Y. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in ApoE-deficient mice. Circ Res 2003; 93:e76-e86.
23. Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med 2002; 346:5-15.
24. Simper D, Wang S, Deb A, et al. Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis.Circulation 2003; 108:143-149.
25. Zeiffer U, Schober A, Lietz M, et al. Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by P-selectin and chemokines. Circ Res 2004; 94:776-784.
26. Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8:403-409.
27. Hu Y,Mayr M,Metzler B, et al. Both donor and recipient origins of smoothmuscle cells in vein graft atherosclerotic lesions. Circ Res 2002; 91:e13-e20.
28. Owens GK.Growth response of tetraploid smoothmuscle cells to balloon embolectomy-induced vascular injury in the spontaneously hypertensive rat. Am Rev Respir Dis 1989; 140:1467-1470.
29. Shimizu K, Sugiyama S, Aikawa M, et al. Host bonemarrow cells are a source of donor intimal smoothmuscle-like cells inmurine aortic transplant arteriopathy. Nat Med 2001; 7:738-741.
30. Xu Y,Arai H, Zhuge X, et al.Role of bone marrow-derived progenitor cells in cuff-induced vascular injury in mice. Arterioscler Thromb Vasc Biol 2004; 24:477-482.
31. Rotmans JI, Heyligers JM, Verhagen HJ, et al. In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation 2005; 112:12-18.
32. Caplice NM, Bunch TJ, Stalboerger PG, et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci USA 2003; 100:4754-4759.
33. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89:E1-E7.
34. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348:593-600.
35. Nabel EG, Plautz G, Boyce FM, et al. Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science 1989; 244:1342-1344.
36. Conte MS, VanMeter GA, Akst LM, et al. Endothelial cell seeding influences lesion development following arterial injury in the cholesterol-fed rabbit. Cardiovasc Res 2002; 53:502-511.
37. Griese DP, Ehsan A, Melo LG, et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 2003; 108:2710-2715.
38. Werner N, Junk S, Laufs U, et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003; 93:e17-e24.
39. Shi Q, Bhattacharya V,Hong-DeWu M, Sauvage LR.Utilizing granulocyte colony-stimulating factor to enhance vascular graft endothelialization from circulating blood cells. Ann Vasc Surg 2002; 16:314-320.
40. Kang HJ,Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004; 363:751-756.
41. Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001; 103:2885-2890.
42. Murohara T, Ikeda H, Duan J, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105:1527-1536.
43. Kalka C,Masuda H, Takahashi T, et al. Vascular endothelial growth factor (165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 2000; 86:1198-1202.
44. Zuk PA, Zhu M,Mizuno H, et al.Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7:211-228.
45. Williams SK,RoseDG, Jarrell BE.Microvascular endothelial cell sodding of ePTFE vascular grafts: improved patency and stability of the cellular lining. J Biomed Mater Res 1994; 28:203-212.
46. Nugent HM, Edelman ER. Endothelial implants provide long-term control of vascular repair in a porcine model of arterial injury. J Surg Res 2001; 99:228-234.
47. Nugent HM, Groothuis A, Seifert P, et al. Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig. J Vasc Res 2002; 39:524-533.
48. Shirota T, He H, Yasui H, Matsuda T. Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. Tissue Eng 2003; 9:127-136.
49. Kaushal S, Amiel GE, Guleserian KJ, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001; 7:1035-1040.
50. Shirota T, Yasui H, Shimokawa H, Matsuda T. Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue. Biomaterials 2003; 24:2295-2302.
51. Choi JH, Hur J, Yoon CH, et al. Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase kinase-3beta activity. J Biol Chem 2004; 279:49430-49438.
52. Cho HJ, YounSW, Cheon SI, et al. Regulation of endothelial cell and endothelial progenitor cell survival and vasculogenesis by integrin-linked kinase. Arterioscler Thromb Vasc Biol 2005; 25:1154-1160.
53. Nugent MA, Nugent HM, Iozzo RV, et al. Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia. Proc Natl Acad Sci USA 2000; 97:6722-6727.
54. Kalka C, Tehrani H, Laudenberg B, et al. VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease. Ann Thorac Surg 2000; 70:829-834.
55. Kong D, Melo LG, Mangi AA, et al. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 2004; 109:1769-1775.
56. Murasawa S, Llevadot J, Silver M, et al. Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 2002; 106:1133-1139.